Familial amyloidosis screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Familial amyloidosis}} {{CMG}} {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for amyloidosis. ==Scre...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Familial amyloidosis}} | {{Familial amyloidosis}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}}{{Fs}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for amyloidosis. | There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for amyloidosis. | ||
Latest revision as of 16:09, 21 November 2019
|
Familial amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Familial amyloidosis screening On the Web |
|
American Roentgen Ray Society Images of Familial amyloidosis screening |
|
Risk calculators and risk factors for Familial amyloidosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
There is insufficient evidence to recommend routine screening for amyloidosis.
Screening
There is insufficient evidence to recommend routine screening for amyloidosis.